检索结果 - Wendtner, C-M

Temporäre Hyposmie bei COVID-19-Patienten 由 Bocksberger, S., Wagner, W., Hummel, T., Guggemos, W., Seilmaier, M., Hoelscher, M., Wendtner, C.-M.

获取全文 获取全文 获取全文

Prediction of poor outcome in CLL patients following first-line treatment with fludarabine, cyclophosphamide and rituximab 由 Fink, A M, Böttcher, S, Ritgen, M, Fischer, K, Pflug, N, Eichhorst, B, Wendtner, C-M, Winkler, D, Bühler, A, Zenz, T, Staib, P, Mayer, J, Hensel, M, Hopfinger, G, Wenger, M, Fingerle-Rowson, G, Döhner, H, Kneba, M, Stilgenbauer, S, Busch, R, Hallek, M

获取全文 获取全文 获取全文

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial 由 Bühler, A, Wendtner, C-M, Kipps, T J, Rassenti, L, Fraser, G A M, Michallet, A-S, Hillmen, P, Dürig, J, Gregory, S A, Kalaycio, M, Aurran-Schleinitz, T, Trentin, L, Gribben, J G, Chanan-Khan, A, Purse, B, Zhang, J, De Bedout, S, Mei, J, Hallek, M, Stilgenbauer, S

获取全文 获取全文 获取全文

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib 由 Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, P B, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, C-M, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U

获取全文 获取全文 获取全文